Ressources

Impact of Hospital Visitor Restrictions during the COVID‑19 Pandemic

Product: — Science Table

Hospital Care Practice Guidelines

covid19-sciencetable.ca Dernière mise à jour: mai 28, 2021

COVID-19 Post-Vaccine Risks, Activities, and Public Health Measures

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Dernière mise à jour: mai 12, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 11, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in Emergency Department and Inpatient Settings

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 10, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in the Outpatient Setting

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 10, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Lay Summary

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 7, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 7, 2021

A Vaccination Strategy for Ontario COVID‑19 Hotspots and Essential Workers

Product: — Science Table

Future Planning Models Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: avril 23, 2021

Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) following AstraZeneca COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in Emergency Department and Inpatient Settings

Product: — Science Table

Clinicians Healthcare Workers Regulation & Policy Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: avril 2, 2021

Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) following AstraZeneca COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in the Outpatient Setting

Product: — Science Table

Healthcare Workers Immune System Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: avril 2, 2021